Isfahan University of Medical Sciences

Science Communicator Platform

Stay connected! Follow us on X network (Twitter):
Share this content! On (X network) By
A Comparison Between Adjuvant and Delivering Functions of Iron Oxide and Calcium Phosphate Nanoparticles, Using a Model Protein Against Brucella Melitensis Publisher



Goudarzi T1 ; Abkar M1 ; Fasihiramandi M2 ; Peikar M3 ; Zamanzadeh Z1
Authors
Show Affiliations
Authors Affiliations
  1. 1. Department of Genetics, Faculty of Biological Sciences and Technology, Shahid Ashrafi Esfahani University, Isfahan, Iran
  2. 2. Molecular Biology Research Center, Systems Biology and Poisonings Institute, Baqiyatallah University of Medical Sciences, Tehran, Iran
  3. 3. Hematology/Oncology Division, Department of Internal Medicine, Isfahan University of Medical Science, Isfahan, Iran

Source: Clinical and Experimental Vaccine Research Published:2025


Abstract

Purpose: Calcium phosphate (CaP) and iron oxide (IO) nanoparticles (NPs) are promising adjuvants and delivery systems for vaccination. Furthermore, it has been shown that the chimeric antigen TF/Bp26/Omp31 (TBO) is a good candidate for stimulating protection against virulent Brucella melitensis. Our aim in the present study was to compare the roles of CaP and IO NPs for induction of the immune response and protection against B. melitensis 16M by using the TBO antigen as a model protein. Materials and Methods: The tbo gene was expressed in the bacterial host and was evaluated by SDS-PAGE and western blot. The recombinant TBO was loaded onto CaP (CaP/ TBO) and IO (IO/TBO) NPs. CaP/TBO and IO/TBO NPs were administered subcutaneously. Results: Antibody levels showed that immunization with both CaP/TBO and IO/TBO NPs stimulated mixed Th1-Th2 immune responses. In addition, immunized mice were challenged with a virulent strain of B. melitensis 16M. Immunized mice with CaP/TBO NPs showed a higher degree of protection than vaccinated animals with IO/TBO NPs. Conclusion: Altogether, our results indicated that the CaP NPs are a potent adjuvant and delivery system for subcutaneously administered Brucella antigens. © Korean Vaccine Society.
Related Docs
1. Development of New Generation of Vaccines for Brucella Abortus, Heliyon (2018)
2. Design and Characterization of a Recombinant Brucella Abortus Rb51 Vaccine That Elicits Enhanced T Cell-Mediated Immune Response, Vaccines (2022)
3. In Silico Design, Cloning and High Level Expression of L7/L12-Tomp31 Fusion Protein of Brucella Antigens, Research in Pharmaceutical Sciences (2015)
4. Possible Health Risks Associated With Nanostructures in Food, Safety and Regulatory Issues of Nanoencapsulated Food Ingredients (2021)
5. Leishmanicidal Activities of Biosynthesized Baco3 (Witherite) Nanoparticles and Their Biocompatibility With Macrophages, Bioprocess and Biosystems Engineering (2021)
6. Production and Characterization of Monoclonal Antibodies Against Brucella Abortus S (99) Surface Antigens, Iranian Biomedical Journal (2002)
7. Induction of Immune Responses by Dna Vaccines Formulated With Dendrimer and Poly (Methyl Methacrylate) (Pmma) Nano-Adjuvants in Balb/C Mice Infected With Leishmania Major, Open Access Macedonian Journal of Medical Sciences (2018)
Experts (# of related papers)
View all Related Experts
Hossein Khanahmad (2)
Ali Jahanian Najafabadi (1)